Stratatech lands major government contract

Madison-based Stratatech secured a contract with the U.S. Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) that could bring the local company $47.2 million over the next five years. For more than 10 years, Stratatech has been developing skin tissue products to treat severe burns. In January, it released positive clinical trial results showing 17 of 20 burn patients treated with its StrataGraft skin product saw their wounds fully close in three months and 19 of the 20 avoided painful skin grafts of their own skin.

The BARDA award means Stratatech has enough money to get StrataGraft through all remaining clinical trails and into the market in about five years. It also allows the company to add between 10 and 20 employees over the next five years. CEO Lynn Allen-Hoffmann said in a Wisconsin State Journal report that Stratatech is the first company in the state to be awarded such a contract.